Association de Neuro-Oncologues d’Expression Francaise Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT03663725
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Association de Neuro-Oncologues d’Expression Francaise